Kim Sigaloff together with Jan Prins and Michiel van Agtmael received a ZonMW grant to investigate the optimal treatment duration for complicated Staphylococcus aureus bacteremia

Kim Sigaloff together with Jan Prins and Michiel van Agtmael received a ZonMW grant (€520.000) to investigate the optimal treatment duration for complicated Staphylococcus aureus bacteremia. In the SAFE-trial (Safe shortening of antibiotic treatment duration for complicated Staphylococcus aureus bacteremia) participants will be randomized to receive either 4 or 6 weeks of antibiotic treatment. David Buis, MD, has started as PhD candidate in March 2020 and will coordinate the SAFE-trial.